Neuroderm Ltd Ord Sh (NDRM)
38.85 -0.05 (-0.13%) 10/17/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,988 | -13,051 | -32,496 | -21,400 | -12,300 |
| Depreciation Amortization | 84 | 43 | 90 | 61 | 31 |
| Accounts payable and accrued liabilities | 1,110 | 287 | 2,725 | 1,310 | 1,041 |
| Other Working Capital | 661 | -3 | 660 | 27 | 164 |
| Other Operating Activity | 5,124 | 2,601 | 1,237 | 1,634 | 911 |
| Operating Cash Flow | $-21,009 | $-10,123 | $-27,784 | $-18,368 | $-10,153 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -67,750 | -75,000 | -30,000 | 7,000 | -1,000 |
| PPE Investments | -344 | -226 | -853 | -610 | -57 |
| Other Investing Activity | -56 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-68,150 | $-75,226 | $-30,853 | $6,390 | $-1,057 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | 3 | 81,046 | 210 | 107 |
| Financing Cash Flow | $5 | $3 | $81,046 | $210 | $107 |
| Exchange Rate Effect | N/A | N/A | N/A | 72 | N/A |
| Beginning Cash Position | 107,178 | 107,178 | 84,735 | 84,735 | 84,735 |
| End Cash Position | 18,176 | 21,925 | 107,178 | 73,039 | 73,692 |
| Net Cash Flow | $-89,002 | $-85,253 | $22,443 | $-11,696 | $-11,043 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,009 | -10,123 | -27,784 | -18,368 | -10,153 |
| Capital Expenditure | -344 | -226 | -853 | -610 | -57 |
| Free Cash Flow | -21,353 | -10,349 | -28,637 | -18,978 | -10,210 |